Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00358306 · ClinicalTrials.gov registry record
The Role of Endothelium Dysfunction in Progression of CKD (Chronic Kidney Disease) After AKI (Acute Kidney Injury)
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 36
- Enrollment target
NCT00358306 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 36 participants.
The verdict
NCT00358306 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
To understand how AKI (Acute Kidney Injury) leads to chronic kidney disease so therapies can be found to alter the progression of events thereby significantly impacting the long-term outcomes of children who develop AKI.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00358306
The ClinicalTrials.gov registry entry for NCT00358306 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00358306 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00358306 about?
NCT00358306 is a clinical study titled "The Role of Endothelium Dysfunction in Progression of CKD (Chronic Kidney Disease) After AKI (Acute Kidney Injury)". To understand how AKI (Acute Kidney Injury) leads to chronic kidney disease so therapies can be found to alter the progression of events thereby significantly impacting the long-term outcomes of children who develop AKI.
What is the current status of trial NCT00358306?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2008-04. Estimated completion is 2009-07.
Who is sponsoring clinical trial NCT00358306?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.